These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 24035919)
21. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease. Burbulla LF; Jeon S; Zheng J; Song P; Silverman RB; Krainc D Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619543 [TBL] [Abstract][Full Text] [Related]
22. Mitochondrial dysfunction in genetic animal models of Parkinson's disease. Trancikova A; Tsika E; Moore DJ Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447 [TBL] [Abstract][Full Text] [Related]
23. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease. Kumar M; Srikanth MP; Deleidi M; Hallett PJ; Isacson O; Feldman RA Hum Mol Genet; 2023 May; 32(11):1888-1900. PubMed ID: 36752535 [TBL] [Abstract][Full Text] [Related]
24. Parkinson's Disease-Related Genes and Lipid Alteration. Fais M; Dore A; Galioto M; Galleri G; Crosio C; Iaccarino C Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299248 [TBL] [Abstract][Full Text] [Related]
25. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology. Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A Cells; 2021 Sep; 10(9):. PubMed ID: 34572052 [TBL] [Abstract][Full Text] [Related]
27. The role of oxidative stress in Parkinson's disease. Dias V; Junn E; Mouradian MM J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804 [TBL] [Abstract][Full Text] [Related]
28. Pluripotent Stem Cells for Modelling and Cell Therapy of Parkinson's Disease. Lebedeva OS; Lagarkova MA Biochemistry (Mosc); 2018 Sep; 83(9):1046-1056. PubMed ID: 30472943 [TBL] [Abstract][Full Text] [Related]
35. Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation. Bono F; Mutti V; Devoto P; Bolognin S; Schwamborn JC; Missale C; Fiorentini C Neurobiol Aging; 2021 Mar; 99():65-78. PubMed ID: 33422895 [TBL] [Abstract][Full Text] [Related]
36. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487 [TBL] [Abstract][Full Text] [Related]
37. Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease. Zhang K; Zhu S; Li J; Jiang T; Feng L; Pei J; Wang G; Ouyang L; Liu B Acta Pharm Sin B; 2021 Oct; 11(10):3015-3034. PubMed ID: 34729301 [TBL] [Abstract][Full Text] [Related]
38. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease. Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287 [TBL] [Abstract][Full Text] [Related]
39. Lysosomal impairment in Parkinson's disease. Dehay B; Martinez-Vicente M; Caldwell GA; Caldwell KA; Yue Z; Cookson MR; Klein C; Vila M; Bezard E Mov Disord; 2013 Jun; 28(6):725-32. PubMed ID: 23580333 [TBL] [Abstract][Full Text] [Related]
40. Impaired Sonic Hedgehog Responsiveness of Induced Pluripotent Stem Cell-Derived Floor Plate Cells Carrying the LRRK2-I1371V Mutation Contributes to the Ontogenic Origin of Lower Dopaminergic Neuron Yield. Potdar C; Jagtap S; Singh K; Yadav R; Pal PK; Datta I Stem Cells Dev; 2024 Jun; 33(11-12):306-320. PubMed ID: 38753688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]